126 related articles for article (PubMed ID: 8770126)
1. Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats.
Melaragno MG; Fink GD
Am J Physiol; 1996 Aug; 271(2 Pt 2):H806-11. PubMed ID: 8770126
[TBL] [Abstract][Full Text] [Related]
2. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
Qiu C; Engels K; Baylis C
Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency.
Li Q; Dale WE; Hasser EM; Blaine EH
Am J Physiol; 1996 Jul; 271(1 Pt 2):R200-7. PubMed ID: 8760221
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta.
Kato H; Hou J; Chobanian AV; Brecher P
Hypertension; 1996 Aug; 28(2):153-8. PubMed ID: 8707375
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
[TBL] [Abstract][Full Text] [Related]
12. Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
Nafrialdi N; Jover B; Mimran A
J Cardiovasc Pharmacol; 1994 May; 23(5):765-71. PubMed ID: 7521459
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Anderson IK; Drew GM
Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
[TBL] [Abstract][Full Text] [Related]
14. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats.
Kucuk M; Kaya M; Kalayci R; Cimen V; Kudat H; Arican N; Elmas I; Korkut F
Life Sci; 2002 Jul; 71(8):937-46. PubMed ID: 12084390
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II: nitric oxide interaction and the distribution of blood flow.
Sigmon DH; Beierwaltes WH
Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267
[TBL] [Abstract][Full Text] [Related]
16. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
17. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations.
Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA
Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696
[TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
Lee BH; Shin HS
Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene.
Moriguchi A; Brosnihan KB; Kumagai H; Ganten D; Ferrario CM
Am J Physiol; 1994 Apr; 266(4 Pt 2):R1273-9. PubMed ID: 8184972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
